{"transactions":[{"id":1845684,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2023-06-23T17:36:22.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 22, 2023, with the first quarterly installment vesting on September 22, 2023, subject to continued service on the company's Board of Directors through each vesting date."}],"balance_after":1200,"derivative":{"exercise_price":12.99,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001209191-23-039479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919123039479/doc4.xml","form_type":"4"}},{"id":2233169,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2022-06-14T08:16:36.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 10, 2022, with the first quarterly installment vesting on September 10, 2022."}],"balance_after":10000,"derivative":{"exercise_price":0.3699,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-036573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919122036573/doc4.xml","form_type":"4"}},{"id":2681603,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2021-06-04T07:14:25.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 2, 2021, with the first quarterly installment vesting on September 2, 2021."}],"balance_after":10000,"derivative":{"exercise_price":3.75,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-038108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919121038108/doc4.xml","form_type":"4"}},{"id":3107740,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2020-06-17T16:58:53.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 15, 2020, with the first quarterly installment vesting on September 15, 2020."}],"balance_after":15000,"derivative":{"exercise_price":0.8512,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-037303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919120037303/doc4.xml","form_type":"4"}},{"id":3481744,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2019-06-21T07:55:59.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 19, 2019, with the first quarterly installment vesting on September 19, 2019."}],"balance_after":15000,"derivative":{"exercise_price":7.54,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-038364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919119038364/doc4.xml","form_type":"4"}},{"id":3880773,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2018-06-29T07:46:15.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 27, 2018, with the first quarterly installment vesting on September 27, 2018."}],"balance_after":15000,"derivative":{"exercise_price":28.15,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-039991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118039991/doc4.xml","form_type":"4"}},{"id":4296615,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Stock Option","published_at":"2017-06-02T09:02:30.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments over 12 months beginning on May 31, 2017, with the first quarterly\ninstallment vesting on August 31, 2017."}],"balance_after":15000,"derivative":{"exercise_price":13.8,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-036992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117036992/doc4.xml","form_type":"4"}},{"id":4379009,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-20T23:29:57.000Z","date":"2017-03-15","kind":"tax_withholding","acquired":false,"shares":96999,"price":0.68,"value":65959.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld in satisfaction of tax withholding obligations."}],"balance_after":1282932,"source":{"system":"sec-edgar","filing":"0001354488-17-000426","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/34956/000135448817000426/issuerdirect_section16.xml","form_type":"4"}},{"id":4379008,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-20T23:29:57.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":213420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued as payment of a portion of Mr. Kelley's bonus set forth in his employment agreement."}],"balance_after":1379931,"source":{"system":"sec-edgar","filing":"0001354488-17-000426","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000135448817000426/issuerdirect_section16.xml","form_type":"4"}},{"id":4516472,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":111989,"kind":"person","name":"Kelley John P","position":1,"cik":"0001310470","reported_name":"Kelley John P","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-20T20:13:58.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in four equal annual installments beginning on December 15, 2017."}],"balance_after":120000,"derivative":{"exercise_price":2.07,"expiration_date":"2026-12-15","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001354488-16-008683","document":"issuerdirect_section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000135448816008683/issuerdirect_section16.xml","form_type":"4"}}]}